~ What Is the Proper Dose of Melatonin? - References

1. de Lourdes M, et al. Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment. Pineal Res 2000 Nov;29(4):193-200.

2. Harrison's Online http://www.medscape.com/HOL/public/HOL-journal.html. Effects of Melatonin on Sleep. Richard J. Wurtman, Cecil H. Green Distinguished Professor and Director, Clinical Research Center, MIT, Cambridge, MA [Copyright © 1998, 1999, 2000 by The McGraw-Hill Companies, Inc. Reproduced with permission of The McGraw-Hill Companies.]

3. Dawson D, et al. Effect of sustained nocturnal transbuccal melatonin administration on sleep and temperature in elderly insomniacs. J Biol Rhythms 1998 Dec;13(6):532-8.

4. Suhner A, et al. Comparative study to determine the optimal melatonin dosage form for the alleviation of jet lag. Chronobiol Int 1998 Nov;15(6):655-66.

5. Sack RL, et al. Entrainment of free-running circadian rhythms by melatonin in blind people. N Engl J Med 2000 Oct 12;343(15):1070-7.

6. Dalton EJ, et al. Use of slow-release melatonin in treatment-resistant depression. J Psychiatry Neurosci 2000 Jan;25(1):48-52.

7. Matsumoto M. The hypnotic effects of melatonin treatment on diurnal sleep in humans. Psychiatry Clin Neurosci 1999 Apr;53(2):243-5.

8. Zhdanova IV, et al. Effects of a low dose of melatonin on sleep in children with Angelman syndrome. J Pediatr Endocrinol Metab 1999 Jan-Feb;12(1):57-67.

9. Jan JE, et al. Melatonin treatment of non-epileptic myoclonus in children. Dev Med Child Neurol 1999 Apr;41(4):255-9.

10. Miyamoto A, et al. Serum melatonin kinetics and long-term melatonin treatment for sleep disorders in Rett syndrome. Brain Dev 1999 Jan;21(1):59-62.

11. Domzal TM, et al. [Melatonin in sleep rhythm disorders after cerebral stroke]. Pol Merkuriusz Lek 2000 Jun;8(48):411-2.

12. Garfinkel D, et al. Facilitation of benzodiazepine discontinuation by melatonin: a new clinical approach. Arch Intern Med 1999 Nov 8;159(20):2456-60.

13. Brusco LI, et al. Effect of melatonin in selected populations of sleep-disturbed patients. Biol Signals Recept 1999 Jan-Apr;8(1-2):126-31.

14. Fauteck J, et al. Melatonin in epilepsy: first results of replacement therapy and first clinical results. Biol Signals Recept 1999 Jan-Apr;8(1-2):105-10.

15. Dagan Y, et al. Rapid reversal of tolerance to benzodiazepine hypnotics by treatment with oral melatonin: a case report. Eur Neuropsychopharmacol 1997 May;7(2):157-60.

16. Pillar G, et al. Melatonin treatment in an institutionalised child with psychomotor retardation and an irregular sleep-wake pattern. Arch Dis Child 1998 Jul;79(1):63-4.

17. Gordon N. The therapeutics of melatonin: a paediatric perspective. Brain Dev 2000 Jun;22(4):213-7.

18. Kunz D, et al. Melatonin as a therapy in REM sleep behavior disorder patients: an open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation. Mov Disord 1999 May;14(3):507-11.

19. Jean-Louis G, et al. Melatonin effects on sleep, mood, and cognition in elderly with mild cognitive impairment. J Pineal Res 1998 Oct;25(3):177-83.

20. Kato M, et al. Melatonin treatment for rhythm disorder. Psychiatry Clin Neurosci 1998 Apr;52(2):262-3.

21. Okawa M, et al. Melatonin treatment for circadian rhythm sleep disorders. Psychiatry Clin Neurosci 1998 Apr;52(2):259-60.

22. Melatonin treatment for circadian rhythm sleep disorders. Does exogenous melatonin improve day sleep or night alertness in emergency physicians working night shifts? Ann Emerg Med 1998 Jun;31(6):699-704.

23. Avery D, et al. Guidelines for prescribing melatonin. Ann Med 1998 Feb;30(1):122-30.

24. Shochat T, et al. Melatonin—the key to the gate of sleep. Ann Med 1998 Feb;30(1):109-14.

25. Rosenberg SI, et al. Effect of melatonin on tinnitus. Laryngoscope 1998 Mar;108(3):305-10.

26. Hughes RJ, et al. Sleep-promoting and hypothermic effects of daytime melatonin administration in humans. Sleep 1997 Feb;20(2):124-31.

27. Lushington K, et al. Daytime melatonin administration in elderly good and poor sleepers: effects on core body temperature and sleep latency. Sleep 1997 Dec;20(12):1135-44.

28. Kunz D, et al. Melatonin effects in a patient with severe REM sleep behavior disorder: case report and theoretical considerations. Neuropsychobiology 1997;36(4):211-4.

29. Jan JE, et al. Use of melatonin in the treatment of paediatric sleep disorders. J Pineal Res 1996 Nov;21(4):193-9.

30. Middleton B, et al. Complex effects of melatonin on human circadian rhythms in constant dim light. J Biol Rhythms 1997 Oct;12(5):467-77.

31. Nakamura K, et al. Daily melatonin intake resets circadian rhythms of a sighted man with non-24-hour sleep-wake syndrome who lacks the nocturnal melatonin rise. Psychiatry Clin Neurosci 1997 Jun;51(3):121-7.

32. Yin D. Is carbonyl detoxification an important anti-aging process during sleep? Med Hypotheses 2000 Apr;54(4):519-22.

33. Yu Q, et al. Melatonin inhibits apoptosis during early B-cell development in mouse bone marrow. J Pineal Res 2000 Sep;29(2):86-93.

34. Anisimov VN, et al. Melatonin and colon carcinogenesis. III. Effect of melatonin on proliferative activity and apoptosis in colon mucosa and colon tumors induced by 1,2-dimethylhydrazine in rats. Exp Toxicol Pathol 2000 52(1):71-6.

35. Lissoni P, et al. Immunoendocrine therapy with low-dose subcutaneous interleukin-2 plus melatonin of locally advanced or metastatic endocrine tumors. Oncology 1995 52(2):163-6.

36. Aldeghi R, et al. Low-dose interleukin-2 subcutaneous immunotherapy in association with the pineal hormone melatonin as a first-line therapy in locally advanced or metastatic hepatocellular carcinoma. Eur J Cancer 1994 30A(2):167-70.

37. Neri B, et al. Melatonin as biological response modifier in cancer patients. Anticancer Res 1998 Mar-Apr;18(2B):1329-32.

38. Lissoni P, et al. A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state. J Pineal Res 1997 Aug;23(1):15-9.

39. Kanishi Y, et al. Differential growth inhibitory effect of melatonin on two endometrial cancer cell lines. J Pineal Res 2000 28(4):227-33.

40. El-Missiry MA, et al. Influence of melatonin on proliferation and antioxidant system in Ehrlich ascites carcinoma cells. Cancer Lett 2000 151(2):119-25.

41. Reiter RJ, et al. Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo. Biol Signals Recept 2000 May-Aug;9(3-4):160-71.

42. Scalbert E, et al. [Melatonin and regulation of the cardiovascular system]. Therapie 1998 Sep-Oct;53(5):459-65.

43. Fontenot J.M., et al. Melatonin deficiency: Its role in oncogenesis and age-related pathology. Journal of Orthomolecular Medicine (Canada) 1990, 5/1 (22-24).

44. Li ZR, et al. Cataractogenesis and lipid peroxidation in newborn rats treated with buthionine sulfoximine: preventive actions of melatonin. J Pineal Res 1997 Apr;22(3):117-23Erratum in: J Pineal Res 1997 Nov;23(4):230.

45. Srinivasan V. Melatonin, biological rhythm disorders and phototherapy. Indian J Physiol Pharmacol 1997 Oct;41(4):309-28.

46. McArthur AJ, et al. Sleep dysfunction in Rett syndrome: a trial of exogenous melatonin treatment. Dev Med Child Neurol 1998 Mar;40(3):186-92.

47. Dagan Y, et al. Evaluating the role of melatonin in the long-term treatment of delayed sleep phase syndrome (DSPS). Chronobiol Int 1998 Mar;15(2):181-90.

48. Nagtegaal JE, et al. Traumatic brain injury-associated delayed sleep phase syndrome. Funct Neurol 1997 Nov-Dec;12(6):345-8.

49. Nagtegaal JE, et al. Effects of melatonin on the quality of life in patients with delayed sleep phase syndrome. J Psychosom Res 2000 Jan;48(1):45-50.

50. Shilo L, et al. Effect of melatonin on sleep quality of COPD intensive care patients: a pilot study. Chronobiol Int 2000 Jan;17(1):71-6.

51. Shamir E, et al. Melatonin improves sleep quality of patients with chronic schizophrenia. J Clin Psychiatry 2000 May;61(5):373-7.

52. Grin W, et al. A significant correlation between melatonin deficiency and endometrial cancer. Gynecol Obstet Invest 1998;45(1):62-5.

53. Hoyos M, et al. Serum cholesterol and lipid peroxidation are decreased by melatonin in diet-induced hypercholesterolemic rats. J Pineal Res 2000 Apr;28(3):150-5.

54. Vollrath L., et al. Day/night serotonin levels in the pineal gland of male BALB/c mice with melatonin deficiency. Acta Endocrinologica (Denmark) 1988, 117/1 (93- 98).

55. O'Hare J.P., et al. Does melatonin deficiency cause the enlarged genitalia of the fragile-X syndrome? Clinical Endocrinology (United Kingdom) 1986, 24/3 (327-333).

56. Scalbert E, et al. [Melatonin and regulation of the cardiovascular system]. Therapie 1998 Sep-Oct;53(5):459-65.

57. Garcia-Maurino S, et al. Melatonin activates Th1 lymphocytes by increasing IL-12 production. Life Sci 1999;65(20):2143-50.

58. Waldhauser F, et al. Alterations in nocturnal serum melatonin levels in humans with growth and aging. J Clin Endocrinol Metab 1988 Mar;66(3):648-52.

59. Brzezinski A. Melatonin in humans. N Engl J Med 1997 Jan 16;336(3):186-95.

60. Zeitzer JM, et al. Do plasma melatonin concentrations decline with age? Am J Med 1999 Nov;107(5):432-6 61.

61. Garfinkel D, et al. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 1995 Aug 26;346(8974):541-4.

62. Saletu B. [Melatonin—a natural hypnotic]? Wien Klin Wochenschr 1997 Oct 3;109(18):714-21.

63. Zisapel N. The use of melatonin for the treatment of insomnia. Biol Signals Recept 1999 Jan-Apr;8(1-2):84-9.

64. Blaicher W, et al. Melatonin in postmenopausal females. Arch Gynecol Obstet 2000 Feb;263(3):116-8.

Free Shipping in the Continental U.S. on Orders over $50
The statements made here have not been evaluated by the FDA. The foregoing statements are based upon sound and reliable studies, and are meant for informational purposes. Consult with your medical practitioner to determine the underlying cause of your symptoms. Please always check your purchase for possible allergins and correct dosage on the bottle before use.

While we work to ensure that product information is correct, on occasion manufacturers may alter their ingredient lists. Actual product packaging and materials may contain more and/or different information than that shown on our Web site. We recommend that you do not solely rely on the information presented and that you always read labels, warnings, and directions before using or consuming a product. For additional information about a product, please contact the manufacturer. Content on this site is for reference purposes and is not intended to substitute for advice given by a physician, pharmacist, or other licensed health-care professional. You should not use this information as self-diagnosis or for treating a health problem or disease. Contact your health-care provider immediately if you suspect that you have a medical problem. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease or health condition. Life Ex Online assumes no liability for inaccuracies or misstatements about products.